Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of PCSK9 plasma levels with metabolic patterns and coronary atherosclerosis in patients with stable angina.

Cardiovascular diabetology - 31 Oct 2019

Caselli Chiara, Del Turco Serena, Ragusa Rosetta, Lorenzoni Valentina, De Graaf Michiel, Basta Giuseppina, Scholte Arthur, De Caterina Raffaele, Neglia Danilo

Abstract excerpt

OBJECTIVE: Aim of this study was to evaluate the relationship of plasma PCSK9 with metabolic and inflammatory profile and coronary atherosclerotic burden in patients with suspected CAD enrolled in the EVINCI study. METHODS: PCSK9 was measured in 539 patients (60.3 ± 8.6 years, 256 males) with symptoms of CAD characterized by risk factors, bio-humoral profiles, and treatment. N = 412 patients underwent coronary...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Computed Tomography Angiography
Share to Coronary Angiography

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Coronary Artery Disease

Share to Energy Metabolism

Share to Inflammation Mediators

Share to Metabolic Syndrome

Share to Plaque, Atherosclerotic

Share to Proprotein Convertase 9

Source

Open in PubMed Open full text

Identifiers

PMID: 31672148
DOI: 10.1186/s12933-019-0949-3
PMCID: PMC6824037

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of PCSK9 plasma levels with metabolic patterns and coronary atherosclerosis in patients with stable angina.PMID 31672148Read ↗

Circulating PCSK9 in patients with type 2 diabetes and related metabolic disorders.Semantic proximity Read ↗

Association of PCSK9 Variants With the Risk of Atherosclerotic Cardiovascular Disease and Variable Responses to PCSK9 Inhibitor TherapySemantic proximity Read ↗

Clinical aspects of PCSK9.Semantic proximity Read ↗

Update on the use of PCSK9 inhibitors in adults: Recommendations from an Expert Panel of the National Lipid Association.Semantic proximity Read ↗

PCSK9 and Lipid Metabolism: Genetic Variants, Current Therapies, and Cardiovascular Outcomes.Semantic proximity Read ↗

Genetic Regulation of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Plasma Levels and Its Impact on Atherosclerotic Vascular Disease Phenotypes.Semantic proximity Read ↗

PCSK9 gene Polymorphism and Assessment of Cardiovascular Risk and Prognosis in Patients With Hyperlipidemia: A Retrospective Cohort Study.Semantic proximity Read ↗

Effect of PCSK9 Inhibitors on Regulators of Lipoprotein Homeostasis, Inflammation and CoagulationSemantic proximity Read ↗

Serum PCSK9 levels, but not PCSK9 polymorphisms, are associated with CAD risk and lipid profiles in southern Chinese Han population.Semantic proximity Read ↗

PCSK9 inhibition in myeloid cells enhances cardioprotection beyond its LDL cholesterol-lowering effectsSemantic proximity Read ↗

Molecular determinants of the cardiometabolic phenotype.Semantic proximity Read ↗

PCSK9 loss of function is protective against extra-coronary atherosclerotic cardiovascular disease in a large multi-ethnic cohort.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.